Loading…
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $60M | $-98M | $-114M | $-101M | -55.4% | 115.1% | 20.9% |
| 2024 | $28M | $-76M | $-94M | $-85M | 45.0% | 264.5% | 11.7% |
| 2023 | $8M | $-74M | $-84M | $-85M | 71.6% | - | - |
| 2021 | $0M | $-32M | $-34M | $-30M | -1931.0% | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Revenue | 7.63 | 27.81 | 59.82 |
| Operating Revenue | 7.63 | 27.81 | 59.82 |
| Cost Of Revenue | 18.28 | 27.45 | 35.60 |
| Gross Profit | -10.65 | 0.36 | 24.21 |
| Operating Expense | 69.77 | 85.42 | 130.59 |
| Research And Development | 15.76 | 15.49 | 15.65 |
| Selling General And Administration | 54.01 | 69.94 | 114.94 |
| Total Expenses | 88.05 | 112.88 | 166.19 |
| Operating Income | -80.42 | -85.06 | -106.38 |
| Total Operating Income As Reported | -80.42 | -85.06 | -106.38 |
| EBITDA | -73.74 | -76.31 | -97.98 |
| Normalized EBITDA | -73.74 | -76.31 | -95.33 |
| EBIT | -78.59 | -87.87 | -105.94 |
| Interest Income | - | 0 | 3.20 |
| Interest Expense | 5.63 | 6.23 | 7.73 |
| Net Interest Income | -5.63 | -6.23 | -4.54 |
| Other Non Operating Income Expenses | 1.83 | -2.80 | -0.12 |
| Other Income Expense | 1.83 | -2.80 | -2.77 |
| Interest Income Non Operating | - | 0 | 3.20 |
| Interest Expense Non Operating | 5.63 | 6.23 | 7.73 |
| Net Non Operating Interest Income Expense | -5.63 | -6.23 | -4.54 |
| Pretax Income | -84.22 | -94.10 | -113.68 |
| Tax Provision | 0.02 | 0.02 | 0.14 |
| Tax Rate For Calcs | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | 0 | 0 | -0.56 |
| Net Income Continuous Operations | -84.24 | -94.12 | -113.81 |
| Net Income From Continuing And Discontinued Operation | -84.24 | -94.12 | -113.81 |
| Net Income From Continuing Operation Net Minority Interest | -84.24 | -94.12 | -113.81 |
| Net Income | -84.24 | -94.12 | -113.81 |
| Net Income Common Stockholders | -86.74 | -100.84 | -126.14 |
| Net Income Including Noncontrolling Interests | -84.24 | -94.12 | -113.81 |
| Normalized Income | -84.24 | -94.12 | -111.72 |
| Diluted NI Availto Com Stockholders | -86.74 | -100.84 | -126.14 |
| Basic Average Shares | 19.89 | 19.89 | 24.58 |
| Diluted Average Shares | 19.89 | 19.89 | 24.58 |
| Reconciled Depreciation | 4.86 | 11.56 | 7.97 |
| Reconciled Cost Of Revenue | 18.28 | 27.45 | 35.60 |
| Total Unusual Items | - | - | -2.65 |
| Total Unusual Items Excluding Goodwill | - | - | -2.65 |
| Preferred Stock Dividends | 2.50 | 6.72 | 12.32 |
| Minority Interests | 0 | 0.69 | - |
| Gain On Sale Of Security | - | - | -2.65 |
| Selling And Marketing Expense | 34.92 | 40.68 | - |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd.this co. | KMTS | $1.2B | -10.49 | 5.81 | -55.4% | -10.21 |
| Alphatec Holdings, Inc. | ATEC | $1.2B | - | 98.07 | -1154.3% | - |
| Inspire Medical Systems, Inc. | INSP | $1.2B | 8.36 | 1.56 | 18.6% | 14.32 |
| IRADIMED CORPORATION | IRMD | $1.2B | 53.21 | 12.64 | 23.8% | 41.92 |
| CareDx, Inc. | CDNA |
| $1.2B |
| -55.93 |
| 3.94 |
| -7.0% |
| -248.15 |
| AMN Healthcare Services, Inc. | AMN | $1.2B | - | 1.85 | -14.9% | 19.35 |
| Schrödinger, Inc. | SDGR | $1.2B | -11.47 | 3.25 | -28.4% | -6.61 |
| Wave Life Sciences Ltd. | WVE | $1.2B | - | 2.26 | -39.4% | - |
| Avanos Medical, Inc. | AVNS | $1.2B | - | 1.50 | -9.4% | - |
| Peer Median | - | -1.55 | 2.76 | -12.1% | 14.32 | |